Source Feed: The Globe and Mail
Publication Date: December 9, 2025 - 18:15
Stay informed
Health Canada approves first pill to treat postpartum depression
December 9, 2025
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.
Unpublished Newswire
In a ruling dated Monday, Justice Eleni Yiannakis said the plaintiffs met the conditions for a full trial and that compensatory refunds would be allowed if they win the case.
January 6, 2026 - 21:02 | Alessia Simona Maratta | Global News - Canada
The graffiti incident is just the latest in a series of problems impacting the charity, including thefts of donated items left at the store's back door.
January 6, 2026 - 20:18 | Klaudia Van Emmerik | Global News - Canada
“There’s more inventory than we’ve seen in years, record inventory last year, and for buyers right now there’s more choice than they’ve ever had,” he said.
January 6, 2026 - 20:18 | Victoria Femia | Global News - Canada
Comments
Be the first to comment